Here is a view of what the system looks like. Note the red peak in the lower chart. This indicates that a low has been hit. The horizontal green line intersects the red peak. Where it intersects on the right side of the peak (the trailing edge, as the engineers would say), we have a Buy signal. This Buy signal is clearly earlier than that provided by the 20-day EMA moving above the 50-day EMA, for example. That is the benefit this system attempts to provide, an earlier signal that is still reliable.
To make it interesting, I did put a few dollars on this one though a bit later than the date the system indicated. I consider this signal to be "decent" because the peak is kind of sloppy at the bottom which also causes my Signal-to-Noise indicator to be a bit weak. In any case, if you had bought when the signal indicated (at $1.69 on 8/24/06), you'd be sitting on a 20% profit today, two and a half months after entering the trade.
I'll provide more information on the confirming signal statistics in later posts.
Friday, November 17, 2006
Generex (GNBT) - decent buy signal
Posted by
TradeRadarOperator
on
11/17/2006 06:14:00 PM
Labels:
buy signal,
stock picks,
stock signal,
stock trading system
Blog Archive
-
►
2010
(153)
-
►
August
(15)
- With your ideas we can build a better Alert HQ tog...
- Total Return Ratio -- 11 stocks John Neff might ha...
- Intel cuts outlook -- confirms cautionary signal i...
- Stock Inspector Tips & Tricks -- fix bad "flash cr...
- June Durable Goods -- mixed signals from tech keep...
- Is company guidance worth listening to?
- Q2 earnings scorecard -- believe the guidance or b...
- Two reasonable value stocks raising dividends this...
- Analysts can't agree on outlook for semiconductors...
- Google keeps getting social - and stands to make m...
- A week without posting - here's what I've been up ...
- 15 under-valued stocks to buy on a pullback
- Does finding winning stocks have to be so hard?
- Three weeks of earnings -- it's clear which sector...
- Stocks take a rest -- will they wake up rejuvenate...
-
►
July
(16)
- June Durable Goods -- Tech sector at a tipping poi...
- Earnings finally matter -- and the market recovers...
- Agriculture sector is on fire -- here's a roundup ...
- Value stock with a growth stock chart -- RLI could...
- Earnings scorecard -- two weeks in, where's the ev...
- Stocks show gains two days in a row -- is the rall...
- Bond ETF reversal alert -- but will the rally cont...
- All it takes is one bad day and advantage goes to ...
- Weekly ProShares Review -- foreign stocks grab inv...
- An update to Trade-Radar Stock Inspector is availa...
- Heads up! -- 4 Reasonable Value stocks starting t...
- Market turns on a dime last week -- now, fundament...
- One bad month of data and the wheels come off -- c...
- 7 day losing streak for the Dow but not every stoc...
- 8 steps to simpler investing
- After being wrong for two weeks, am I finally seei...
-
►
June
(16)
- Not dead yet
- May Durable Goods -- Tech wavers but the trend is ...
- Humana tops our "reasonable value" list with some ...
- Weekly ProShares review -- bulls still at work but...
- Say what you will about the fundamentals -- this m...
- Value by Industry -- how do your favorite sectors ...
- Time to buy -- little known small cap could be Gul...
- Weekly ProShares review shows bulls in the ascenda...
- Dare I say it? --- the bottom is in (well, maybe)
- Stocks hold their gains for a whole day -- is it g...
- Warning signs for semiconductors?
- Slide show demonstrates ease of use of new Trade-R...
- Ride the momentum train -- this week's strongest P...
- Mr. Market trips over jobs report - bulls left hid...
- Weekend Winners and Losers for June 4, 2010
- Android - smartest thing Google has done lately?
-
►
August
(15)
| Disclaimer: This site may include market analysis. All ideas, opinions, and/or forecasts, expressed or implied herein, are for informational purposes only and should not be construed as a recommendation to invest, trade, and/or speculate in the markets. Any investments, trades, and/or speculations made in light of the ideas, opinions, and/or forecasts, expressed or implied herein, are committed at your own risk, financial or otherwise. |



Subscribe to













1 comments:
Today’s GNBT’s announcement of Craig Eagle, M.D. to its scientific advisory board is an important move.
Dr. Eagle’s connection with Pfizer is GNBT’s first step toward partnership with Pfizer.
This partnership will open a huge market to GNBT and give Pfizer access to products it does not have.
GNBT is very close to get the FDA approval for its drug delivery system and is going to need Pfizer like company to help put it on the map. Great move by GNBT.
Post a Comment